These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32694064)

  • 21. Pre-operative wait times in high-grade non-endometrioid endometrial cancer: Do surgical delays impact patient survival?
    Nica A; Sutradhar R; Kupets R; Covens A; Vicus D; Li Q; Ferguson SE; Gien LT
    Gynecol Oncol; 2022 Feb; 164(2):333-340. PubMed ID: 34895897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does MMR status in endometrial cancer influence response to adjuvant therapy?
    Kim SR; Pina A; Albert A; McAlpine J; Wolber R; Blake Gilks C; Kwon JS
    Gynecol Oncol; 2018 Oct; 151(1):76-81. PubMed ID: 30172479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of cervical infiltration in Stage II endometrial cancer by different preoperative evaluation techniques (D&C, US, CT, MRI).
    Pete I; Godény M; Tóth E; Radó J; Pete B; Pulay T
    Eur J Gynaecol Oncol; 2003; 24(6):517-22. PubMed ID: 14658593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Cell Type Independent Binary Grading System Does Not Significantly Improve Endometrial Biopsy Interpretation.
    Nastic D; Kahlin F; Dahlstrand H; Carlson JW
    Int J Gynecol Pathol; 2016 May; 35(3):256-63. PubMed ID: 26863477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of pathology in the management of patients with endometrial carcinoma.
    Bartosch C; Pires M; Jerónimo C; Lopes JM
    Future Oncol; 2017 May; 13(11):1003-1020. PubMed ID: 28481146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study.
    Visser NC; Bulten J; van der Wurff AA; Boss EA; Bronkhorst CM; Feijen HW; Haartsen JE; van Herk HA; de Kievit IM; Klinkhamer PJ; Pijlman BM; Snijders MP; Vandenput I; Vos MC; de Wit PE; van de Poll-Franse LV; Massuger LF; Pijnenborg JM
    BMC Cancer; 2015 Jun; 15():487. PubMed ID: 26123742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative radiotherapy for inoperable stage II endometrial cancer: insights into improving treatment and outcomes.
    Lee MH; Aquino-Parsons C; Hoskins PJ; Lim P; Kwon JS
    J Obstet Gynaecol Can; 2013 Jul; 35(7):635-639. PubMed ID: 23876641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are preoperative histology and MRI useful for classification of endometrial cancer risk?
    Body N; Lavoué V; De Kerdaniel O; Foucher F; Henno S; Cauchois A; Laviolle B; Leblanc M; Levêque J
    BMC Cancer; 2016 Jul; 16():498. PubMed ID: 27430321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings.
    Maneschi F; Ceccacci I; Perugini A; Pane C; Simeone A; Manicone A
    Arch Gynecol Obstet; 2012 Feb; 285(2):521-7. PubMed ID: 21779772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.
    Eltabbakh GH; Shamonki J; Mount SL
    Gynecol Oncol; 2005 Nov; 99(2):309-12. PubMed ID: 16005945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between pre-operative and final histological diagnosis on endometrial cancer.
    Shiozaki T; Miwa M; Sakuma T; Suzuki K; Kogiku A; Yamamoto K; Senda T; Yano H; Kitai M; Matsuoka K; Sudo T; Nagao S; Yamaguchi S
    Int J Gynecol Cancer; 2019 Jun; 29(5):886-889. PubMed ID: 30826751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predictive of endometrial carcinoma in patients with atypical endometrial hyperplasia on preoperative histology.
    Touboul C; Piel B; Koskas M; Gonthier C; Ballester M; Cortez A; Daraï E
    Anticancer Res; 2014 Oct; 34(10):5671-6. PubMed ID: 25275072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Endometrial Ablation on Treatment Planning in Women With Endometrial Cancer.
    Argall E; Jovanovic A; Figueroa R; Mayer A; Nelson B; Roland P
    J Minim Invasive Gynecol; 2016 Feb; 23(2):281-5. PubMed ID: 26386387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of two management strategies for preoperative grade 1 endometrial cancer.
    Bernardini MQ; May T; Khalifa MA; Bland AE; Nofech-Mozes S; Berchuck A; Covens A; Havrilesky L
    Obstet Gynecol; 2009 Jul; 114(1):7-15. PubMed ID: 19546752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology.
    Leitao MM; Kehoe S; Barakat RR; Alektiar K; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
    Am J Obstet Gynecol; 2010 Mar; 202(3):278.e1-6. PubMed ID: 20022581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pertinence of the preoperative exploration in the evaluation of the risk of lymph node metastasis in endometrial cancer].
    Groff B; Pouget O; Stoll F; Mathelin C; Baldauf JJ; Akladios CY
    Gynecol Obstet Fertil; 2014 Feb; 42(2):92-96. PubMed ID: 24309027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma.
    Steele E; Umar SA; Bomeisl P; Miedler J; Zanotti KM; Wasman JK; Hunt DC; Abdul-Karim FW
    Diagn Cytopathol; 2012 Feb; 40(2):138-40. PubMed ID: 20891002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of tumour grade 1 and endometrioid cell type on preoperative endometrial biopsy.
    Baek MH; Park YR; Suh DS; Lee SW; Park JY; Kim D; Kim JH; Kim YM; Kim YT; Nam JH
    J Obstet Gynaecol; 2015 Jan; 35(1):79-81. PubMed ID: 25093908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
    Helpman L; Perri T; Lavee N; Hag-Yahia N; Chariski HA; Kalfon S; Derazne E; Beiner ME; Kadan Y; Fishman A; Korach J; Covens A; Gien L
    Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
    Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.